Imprimis Pharmaceuticals plans to price public sale of stock

Bookrunner National Securities to have a 45-day, 15% greenshoe

By Devika Patel

Knoxville, Tenn., March 10 – Imprimis Pharmaceuticals, Inc. said it will price a public offering of common stock with a 45-day, 15% greenshoe.

National Securities Corp. is the bookrunner.

The specialty pharmaceutical company is based in La Jolla, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.